COMPOSITIONS AND METHODS FOR TREATING THYROID DISEASE
The present disclosure relates to a compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating thyroid disease and various thyroid-related disorders. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.
1 . A composition, comprising:
about 0.5 to 3.5 mg of B6;
about 10 to 90 mcg of B12;
about 300 to 700 mcg of iodine;
about 50 to 250 mcg of selenium;
about 4 to 16 mg of zinc;
about 0.5 to 3.5 mg of manganese;
about 25 to 125 mcg of molybdenum;
about 300 to 600 mg of ashwagandha root powder;
about 50 to 170 mg of an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof; and
about 700 to 1300 mg of at least one digestive enzyme.
2 . The composition of claim 1 , further comprising about 40 to 110 mg of L-Tyrosine.
3 . The composition of claim 1 , further comprising about 20 to 80 mg of mullein leaf.
4 . The composition of claim 1 , wherein the composition comprises:
about 2 mg of B6;
about 50 mcg of B12;
about 500 mcg of iodine;
about 150 mcg of selenium;
about 4 to 16 mg of zinc;
about 2 mg of manganese;
about 75 mcg of molybdenum;
about 450 mg of ashwaganda root powder;
about 110 mg of the extract, wherein the extract is the polygonum root extract;
about 1000 mg of a digestive enzyme, wherein the digestive enzyme is DPP-IV;
about 75 mg of L-Tyrosine; and
about 50 mg of mullein leaf.
5 . The composition of claim 1 , wherein the B12 is methylcobalamin.
6 . The composition of claim 1 , further comprising calcium phosphate.
7 . The composition of claim 1 , further comprising copper gluconate.
8 . The composition of claim 1 , wherein the composition does not comprise at least one additive selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, corn, soy, artificial colors, preservatives, fish and shellfish.
9 . The composition of claim 1 , further comprising at least one palatability agent.
10 . The composition of claim 9 , wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates.
11 . The composition of claim 1 , wherein the composition is provided as a dietary supplement.
12 . The composition of claim 1 , wherein the composition is administered orally in the form of a capsule.
13 . The composition of claim 1 , wherein the composition is administered orally in the form of a tablet.
14 . The composition of claim 1 , wherein the digestive enzyme is DPP-IV.
15 . A composition for treating thyroid disease comprising B6, B12, iodine, selenium, zinc, manganese, molybdenum, ashwaganda root powder, an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof, and a digestive enzyme
16 . The composition of claim 15 , further comprising L-Tyrosine
17 . The composition of claim 15 , further comprising mullein leaf.
18 . The composition of claim 15 , further comprising at least one of calcium phosphate, hydroxypropyl methylcellulose, or copper gluconate.
19 . A method for treating a thyroid disease comprising: administering an effective amount of a composition to a patient suffering from the thyroid disease, wherein the composition comprises:
about 0.5 to 3.5 mg of B6;
about 10 to 90 mcg of B12;
about 300 to 700 mcg of iodine;
about 50 to 250 mcg of selenium;
about 4 to 16 mg of zinc;
about 0.5 to 3.5 mg of manganese;
about 25 to 125 mcg of molybdenum;
about 300 to 600 mg of ashwaganda root powder;
about 50 to 170 mg of an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof; and
about 700 to 1300 mg of at least one digestive enzyme.
20 . The method of claim 19 , wherein the thyroid disease is selected from the group consisting of hyperthyroid, and hypothyroid.